ABLYF Recent News What to Watch at Merck, CytRx,
Post# of 6
Posted On: 03/01/2014 11:18:12 PM
ABLYF Recent News
What to Watch at Merck, CytRx, and Mylan This Morning Motley Fool - Mon Feb 03, 8:16AM CST
Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer Marketwire - Mon Aug 19, 12:27AM CDT
ACTIVAERO'S PARTNER ABLYNX INITIATED PHASE I STUDIES IN RESPIRATORY SYNCYTIAL VIRUS (RSV) USING FAVORITE TECHNOLOGY Thomson Reuters ONE - Thu Jul 18, 3:11AM CDT
Ablynx: Publication in Accordance With Articles 14 and 15 of the Belgian Law of 2 May 2007 on the Publication of Major Shareholdings (the "Transparency Law") Marketwire - Fri Mar 08, 11:45AM CST
What to Watch at Merck, CytRx, and Mylan This Morning Motley Fool - Mon Feb 03, 8:16AM CST
Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer Marketwire - Mon Aug 19, 12:27AM CDT
ACTIVAERO'S PARTNER ABLYNX INITIATED PHASE I STUDIES IN RESPIRATORY SYNCYTIAL VIRUS (RSV) USING FAVORITE TECHNOLOGY Thomson Reuters ONE - Thu Jul 18, 3:11AM CDT
Ablynx: Publication in Accordance With Articles 14 and 15 of the Belgian Law of 2 May 2007 on the Publication of Major Shareholdings (the "Transparency Law") Marketwire - Fri Mar 08, 11:45AM CST
(0)
(0)Ablynx Nv (ABLYF) Stock Research Links
Scroll down for more posts ▼